SHANGHAI, May 10, 2024 /PRNewswire/ -- Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO) and a spin-off company of General Biol ...
Located in Yangzhou of East China, Aurisco's new commercial manufacturing site is expected to produce 200 kilograms of oligonucleotides each year. Through the cooperation with Cytiva, Aurisco will ...
Use this brand-new eBook from Cytiva to learn more about the oligonucleotide market as a whole and about the full workflow solutions available today. We hope you enjoy it!
SHANGHAI, Jan. 5, 2023 /PRNewswire/ -- Aurisco, an innovative pharmaceutical company and CDMO (contract development and manufacturing organization) in China, is cooperating with Cytiva, a global ...
Located in Yangzhou of East China, Aurisco's new commercial manufacturing site is expected to produce 200 kilograms of oligonucleotides each year. Through the cooperation with Cytiva, Aurisco will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback